X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

International Journal of Pharmaceutics-X

期刊標題檢索 INT J PHARM-X 最新評論: Great submission experience, assigned two reviewers by the editor, acc... (2024-03-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[International Journal of Pharmaceutics-X]您好,您是該頁面的第 4219 位訪客。

期刊簡介
期刊名稱International Journal of Pharmaceutics-X International Journal of Pharmaceutics-X

(According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is )
LetPub Score
7.1
50 ratings
Rate

Reputation
8.3

Influence
6.0

Speed
7.1

期刊簡稱INT J PHARM-X
ISSN2590-1567
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.600.8011.265
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q249 / 183

自引率 (2023-2024)5.80%自引率趨勢
掲載範囲
官方網站https://www.journals.elsevier.com/international-journal-of-pharmaceutics-x
在線稿件提交
開放訪問Yes
出版商Elsevier
主題領域PHARMACOLOGY & PHARMACY
出版國/地區Netherlands
發行頻率
創刊年0
每年文章數65每年文章數趨勢
黃金OA百分比93.01%
OA Related Info
APC: Yes( USD2200; )
APC waiver:Check Notes
Other charges: No
Keywords: vaccines、biologicals、pharmaceutical sciences、pharmaceutical nanotechnology、drug delivery systems
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ140/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2590-1567%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 17 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【International Journal of Pharmaceutics-X】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645745
    BIOMATERIALS601408
    Frontiers in Pharmacology504183
    BIOMEDICINE & PHARMACOTHERAPY498668
    JOURNAL OF ETHNOPHARMACOLOGY497096
    Journal of Materials Chemistry B476184
    Frontiers in Immunology461449
    COMPUTERS IN BIOLOGY AND MEDICINE420859
    COLLOIDS AND SURFACES B-BIOINTERFACES419559
    Frontiers in Oncology415911
  •  

    International Journal of Pharmaceutics-X International Journal of Pharmaceutics-X
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [International Journal of Pharmaceutics-X] 的評論撰寫評論
作者: Dr Bill


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-27 20:49:48 評論於
Great submission experience, assigned two reviewers by the editor, accepted after one major revision. Currently indexed in Zone 1 of the Chinese Academy of Sciences Pharmacy section. Hope for further improvement in the future and aim to enter Zone 1 of the Medical category soon.

Jan.1, 2024 Submitted to Journal
Jan.2, 2024 With editor
Jan.4, 2024 Under Review
Jan.20, 2024 Under Review
Feb.22, 2024 Revise
Mar.06, 2024 Manuscript revision
Mar.06, 2024 With editor
Mar.08, 2024 Under Review
Mar.18, 2024 Require Reviews Completed
Mar.25, 2024 Accept
(0) 讚! | Dr Bill

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [International Journal of Pharmaceutics-X] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*